It is also worth noting that FTD patients with GRN and C9orf72 mutations have demonstrated a higher likelihood of having elevated levels of serum NfL concentrations compared to those with tau pathology (MAPT mutations) [54]. The gene discussed is C9orf72; the disease is frontotemporal dementia.